This year, sales of Eliquis (apixaban) are projected to decline by 15.2% due to the loss of its European market exclusivity ...

The EU has been pushing for a six to 10 years’ data exclusivity period, which would prevent India from using an innovator's ...

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...

The country’s wavering stance on data exclusivity, which will allow corporations to hold a monopoly on drugs, risks global ...

AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...

Generic drugs are created to offer lower-cost alternatives to more expensive brand-name drugs. Brand-name drugmakers are given periods of patent exclusivity, allowing them to sell their higher-priced ...

Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...

Albertans may see more varieties of Ozempic on the market soon, after a patent on the drug expired two weeks ago.

One of India's biggest drugs companies is urging the government to change the rules on data exclusivity, saying the country needs to balance the interests of multinational pharmaceutical companies and ...

The FDA’s acceptance for filing of our ANDA for fluticasone furoate, umeclidinium, and vilanterol inhalation powder, a generic version of Trelegy® Ellipta®, is another major milestone in advancing our ...